New BPA with takeda pharmaceuticals america, INC. For the period of 03/18/2026 to 03/17/2027 with four one-year option periods.
Ended Awarded Last action
- Contract number
- 36E79726A0012
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI ENNFDLWFC6L1
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 5 $148,898 obligated
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Combined order value
- $148,898 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling <1% used
- $851,917,905.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The VA National Acquisition Center established a Blanket Purchase Agreement with Takeda Pharmaceuticals America, Inc. on March 18, 2026, with a ceiling of $851.9 million, for oncology pharmaceutical supply through March 17, 2027, with four one-year option periods.
The BPA is a single-award vehicle established against the GSA Pharmaceuticals and Drugs Federal Supply Schedule (Schedule 61-IB). Takeda supplies ICLUSIG (ponatinib), a targeted cancer therapy for chronic myeloid leukemia and acute lymphoblastic leukemia, in multiple dosage strengths through this instrument.
Place of performance includes Earth City, Missouri and Cambridge, Massachusetts. Orders are placed by Veterans Integrated Service Networks across the Department of Veterans Affairs healthcare system.
Recent BPA calls issued under this vehicle include a $38,097.52 call for TAKHZYRO 150 mg awarded to VISN 5 on August 20, 2026, completed August 25, 2026 for delivery to Brooks, Kentucky; a $38,097.52 call for TAKHZYRO 150 mg awarded July 31, 2026 to VISN 5 with completion August 4, 2026 at Brooks, Kentucky; a $34,605.34 call for GATTEX 5 mg awarded July 28, 2026 to VISN 5 with completion July 29, 2026 at Carrollton, Texas; and a $38,097.52 call for TAKHZYRO 150 mg awarded July 24, 2026 to VISN 5 with completion July 28, 2026 at Brooks, Kentucky. All calls are priced firm fixed price.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Takhzyro 150 MG | Veterans Integrated Service Network 5 (VHA) | $0 | |
| Takhzyro 150 MG | Veterans Integrated Service Network 5 (VHA) | $38,098 | |
| Takhzyro 150 MG | Veterans Integrated Service Network 5 (VHA) | $38,098 | |
| Gattex 5 MG | Veterans Integrated Service Network 5 (VHA) | $34,605 | |
| Takhzyro 150 MG | Veterans Integrated Service Network 5 (VHA) | $38,098 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Legal Contract Cancellation | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79726A0012?
36E79726A0012 was awarded to Takeda Pharmaceuticals America, Inc. by National Acquisition Center (Headquarters) on March 18, 2026.
How much is contract 36E79726A0012 worth?
Orders under 36E79726A0012 have obligated $148,898. 36E79726A0012's own ceiling is $851,917,905.
How many orders have been placed under contract 36E79726A0012?
5 orders have been placed under 36E79726A0012, the latest on August 27, 2026.
Who can order from contract 36E79726A0012?
36E79726A0012 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79726A0012 under another contract?
Yes. 36E79726A0012 is a blanket purchase agreement under 36F79726D031E, a federal supply schedule.
Was contract 36E79726A0012 competed?
The extent of competition for 36E79726A0012 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV